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Hyperthyroidism may present with signs and symptoms
related to dysfunction of a variety of organs. Cardiovas-
cular pathology in hyperthyroidism is common. A few
case reports describe isolated right heart failure, tri-
cuspid regurgitation, and pulmonary hypertension as
the prominent cardiovascular manifestations of hyper-
thyroidism. Although most textbooks do not mention
hyperthyroidism as a cause of pulmonary hypertension
and isolated right heart failure, the literature suggests
that some hyperthyroid patients may develop reversible
pulmonary hypertension and isolated right heart fail-
ure. We report a case of hyperthyroidism presenting
with signs and symptoms of isolated right heart failure,
tricuspid regurgitation, and pulmonary hypertension,
which resolved with treatment of hyperthyroidism.
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CASE
A 56-year-old previously healthy woman presented with a
3-month history of weight loss (25 lb), dyspnea at rest,
weakness, intermittent palpitations, nervousness, and heat
intolerance. She denied any hair or skin changes, anorexia,
diarrhea, cough, or hemoptysis. She worked as a clerk. She
denied exposure to chemicals, tobacco, alcohol, or illicit drugs.
Her examination revealed a blood pressure of 100/60 mmHg
and decreased oxygen saturation (89% on room air). There was
a diffuse, nontender goiter without palpable nodules. Jugular
venous distention, a pansystolic murmur at the left sternal
border, hepatomegaly, abdominal distention, and bilateral leg
edema were also noted. On EKG, she had atrial fibrillation with
a rate of 110/minute. Laboratory evaluation revealed a white
blood count of 13,800/μL with normal differential, hemoglobin
(Hgb) 9 g/dL, hematocrit 30%, platelet count 157,000/μL,
normal electrolytes, bilirubin 1.9 mg/dL, alkaline phosphatase
187 U/L, aspartic transaminase 170 U/L, alanine transami-
nase 177 U/L, TSH 0.0 IU/mL, and free T4 9.8 ng/dL.
Sedimentation rate, rheumatoid factor, antinuclear antibodies,
and rapid protein reagents were all normal. Chest roentgeno-
gram revealed a prominent left pulmonary artery and possible
pruning of the vessels. Abdominal ultrasound revealed mild
ascites and mildly enlarged liver. Spiral computed tomography
of the chest revealed no evidence of pulmonary embolus. The
patient was diagnosed with hyperthyroidism. Iodine
131 uptake
was low, which was consistent with thyroiditis. However, the
uptake was performed after the contrast computed tomography
ofthechest,whichmighthaveinterferedwiththeiodineuptake.
(The free iodine load of contrast media interferes with iodine
uptake in the thyroid compromising diagnostic thyroid uptake
for about 2 months after administration of contrast media.)
1
The heart rate was controlled with intravenous diltiazem,
and the patient was anticoagulated. The patient was not given
any specific treatment for hyperthyroidism and was dis-
charged on metoprolol and warfarin to be followed up in the
outpatient clinic.
Upon further outpatient follow-up, the patient continued to
be hyperthyroid. Thyroid-stimulating immunoglobulins were
present and a repeat iodine
131 uptake was high. Findings were
consistent with Graves’ disease.
Because of atrial fibrillation and signs and symptoms
suggestive of cardiac dysfunction, an echocardiogram was
performed. This revealed right atrial and ventricular dilatation,
right ventricular systolic dysfunction, severe pulmonic and
tricuspid regurgitation, and an elevated pulmonary artery
systolic pressure of 75 mmHg. There was no left ventricular
systolic or diastolic dysfunction. Left ventricular ejection
fraction was normal at 60%. No structural heart valve
abnormalities were noted. Pulmonary function and sleep
studies were normal. Other causes of pulmonary hyperten-
sion, such as alcohol abuse, HIV infection, and vitamin
deficiency were ruled out.
The patient was treated with methimazole and in a few
weeks became euthyroid in sinus rhythm. At that time liver
function tests normalized and a repeat echocardiogram
revealed a normal size and function of the right ventricle and
only mild tricuspid regurgitation. Pulmonary artery systolic
pressure improved to 45 mmHg.
Anemia improved to a Hgb of 11 g/dL.
DISCUSSION
Adverse cardiovascular effects of hyperthyroidism are well
documented in the literature. High output biventricular heart
failure with normal or decreased systemic and pulmonary
vascular resistance is the expected cardiovascular complica-
tion of hyperthyroidism.
2–4
Isolated right heart failure, variable degrees of tricuspid
regurgitation, pulmonary hypertension, or different combina-
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148tions of the three in patients with thyrotoxicosis have been
infrequently reported.
5–22 Possible mechanisms of these cardiac
abnormalities include increased blood volume
12,17,23,24 or in-
creased right ventricular load because of increased cardiac
output and venous return.
24 The thin-walled structure of the
right ventricle, as opposed to the left ventricle, may render the
right ventricle more susceptible to volume overload. High cardiac
output-induced or autoimmune-induced pulmonary vascular
endothelial injury may lead to pulmonary hypertension.
12,25,26
Increased pulmonary vascular resistance could also result from
increased metabolism of certain pulmonary vasodilating sub-
stances.
26 These cardiac abnormalities in the reported cases
were characterized by the reversibility of the pathology and the
benign clinical course once thyrotoxicosis was treated and
patients became euthyroid.
5–22 However, one report described a
case of pulmonary hypertension and thyrotoxicosis that was
complicated with further arrhythmias and asystole because of
worsened thyrotoxicosis by amiodarone given for atrial fibrilla-
tion.
5 Atrial fibrillation was documented in only 2 of 14 reported
cases of thyrotoxicosis and isolated right heart failure. Both of
these cases had pulmonary hypertension and tricuspid regurgi-
tation that resolved or improved after treatment of hyperthy-
roidism (Table 1).
5–22
In the present case, thyrotoxicosis was associated with
pulmonary hypertension, right ventricular failure, and severe
tricuspid regurgitation, which resolved when the patient
became euthyroid. Secondary causes of pulmonary hyperten-
sion, such as left ventricular failure, pulmonary embolus,
chronic obstructive pulmonary disease, obstructive sleep
apnea, alcohol abuse, HIV, vitamin deficiency, and vasculitides
were ruled out. Our case is consistent with other reported
cases, though it was at the extreme end of the spectrum
regarding the severity of pulmonary hypertension (Table 1).
This may illustrate that even severe pulmonary hypertension
can be reversed when the underlying cause is corrected.
There has been at least one report of a thyrotoxic patient
presenting with isolated right ventricular failure with normal
pulmonary vascular resistance measured by right heart
catheterization.
17 Right ventricular failure and tricuspid re-
gurgitation might be directly related to thyrotoxicosis indepen-
dently from pulmonary hypertension. Most of these cases of
thyrotoxicosis and right ventricular failure and pulmonary
hypertension were diagnosed as Graves’ disease, indicating a
possible autoimmune mechanism for this association.
27
A prospective echocardiographic study of 39 hyperthyroid
patients and 39 matched controls revealed that the mean
pulmonary artery pressure in the hyperthyroid patients was
significantly greater than in controls (38 vs 27 mmHg).
Moderate to severe tricuspid regurgitation was significantly
more common in the hyperthyroid group (7 vs 1). Most of
the hyperthyroid patients did not have documented atrial
fibrillation. These abnormalities resolved in most patients
after 14 months of follow-up. This study and others suggest
that isolated right-sided heart failure and pulmonary hyper-
tension are more common than once thought. If an
echocardiogram is done routinely on patients with hyperthy-
roidism, more of these cardiovascular abnormalities may be
identified.
28
CONCLUSION
In the setting of hyperthyroidism, pulmonary hypertension
and right ventricular dysfunction may be underdiagnosed. The
symptoms are likely to be considered as part of the hyperthy-
roid syndrome. Because the cardiovascular findings resolve
when the patient becomes euthyroid, patients who had these
findings might not be evaluated for them.
5–22 It is important to
consider hyperthyroidism in patients presenting with pulmo-
nary hypertension or unexplained right heart failure. Further-
more, thyroid function evaluation should be included in the
work up of primary pulmonary hypertension. Because amio-
darone may trigger hyperthyroidism in patients with multi-
nodular goiter or worsen coexisting thyrotoxicosis owing to its
iodine content, it should not be used for rhythm or rate control
of atrial fibrillation without ruling out hyperthyroidism or
susceptibility to such condition.
5
It remains unclear why only a subgroup of patients with
thyrotoxicosis is prone to have isolated right heart failure with
or without pulmonary hypertension.
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